N※N

Siemens CEO Signals M&A Push in Software, AI, and Life Sciences

  //science-technology.news-articles.net/content/2 .. s-m-a-push-in-software-ai-and-life-sciences.html
  Published in Science and Technology on Wednesday, January 7th 2026 at 5:25 GMT by Bloomberg L.P.
      Locale: GERMANY

Siemens' Busch Signals M&A Focus on Operations Software, AI, and Life Sciences – A Deep Dive

Siemens AG is poised for a renewed period of strategic acquisitions, particularly within operations software, artificial intelligence, and the burgeoning life sciences sector, according to recent comments from CEO Roland Busch. In a Bloomberg interview published January 6, 2026, Busch outlined a clear ambition for Siemens to bolster its position as a leading technology provider through targeted mergers and acquisitions, building on a period of significant organic growth. This strategy signals a shift towards consolidating gains and proactively shaping future growth areas, rather than solely relying on internal innovation.

Busch emphasized that Siemens, after several years of focusing on internal restructuring and streamlining its portfolio – including the spin-off of Siemens Energy – is now in a robust financial position to pursue “smart” acquisitions. These won’t be large, transformational deals like some of Siemens’ historical moves, but rather focused purchases of companies possessing key technologies and expertise in areas critical to Siemens’ long-term strategy. The Bloomberg article highlights that Siemens has generated approximately €13 billion in free cash flow in the past fiscal year, providing ample resources for these endeavors.

Key Areas of Acquisition Focus:

The CEO specifically highlighted three core areas: operations software, artificial intelligence, and life sciences. Let's break down each of these:

1. Operations Software: Siemens already boasts a substantial presence in industrial automation and digitalization through its Digital Industries division. However, the competitive landscape is rapidly evolving. Companies like Rockwell Automation, Dassault Systèmes, and even tech giants like Microsoft and Amazon are aggressively expanding into industrial software. Busch indicated Siemens is looking to acquire companies that can accelerate the development and deployment of its Xcelerator platform – an open digital business platform designed to help companies create and deliver innovative products and services. This likely involves companies offering specialized software for areas like manufacturing execution systems (MES), supply chain management, product lifecycle management (PLM), and digital twins. The focus is on enhancing the platform’s capabilities and broadening its reach into new industries. Siemens' recent acquisition of Innomotics (reported in a linked article within the Bloomberg piece) exemplifies this strategy – adding expertise in drive technology and digitalization to the Xcelerator ecosystem.

2. Artificial Intelligence: AI is increasingly being integrated into every aspect of Siemens’ offerings, from automation and energy management to healthcare and mobility. However, simply integrating AI isn't enough. Busch made clear that Siemens is interested in acquiring companies possessing "deep tech" AI capabilities – specifically those that have moved beyond basic machine learning and are working on more sophisticated areas like generative AI, edge AI (processing data directly on devices rather than in the cloud), and AI-powered cybersecurity. This is crucial for enabling predictive maintenance, optimizing energy consumption, improving product design, and enhancing operational efficiency. The article suggests Siemens isn't necessarily looking for AI application developers, but rather for companies building the core AI infrastructure and algorithms.

3. Life Sciences: This represents perhaps the most significant new area of strategic focus for Siemens. While traditionally strong in industrial automation, Siemens has been steadily increasing its presence in the healthcare sector with its Siemens Healthineers division. Busch envisions a broader push into the life sciences, encompassing not just medical imaging and diagnostics, but also biopharmaceutical manufacturing and personalized medicine. A linked Reuters article details a recent partnership between Siemens Healthineers and Bio-Techne, a leading provider of protein analysis tools, further illustrating this commitment. The company is expected to acquire companies offering technologies related to cell and gene therapy manufacturing, drug discovery, and advanced diagnostics. The expanding biopharmaceutical industry, fueled by innovations in mRNA vaccines and personalized therapies, presents a significant growth opportunity. The acquisition targets will likely be companies with specialized expertise in areas like bioreactors, filtration systems, and automated cell culture.

Shifting Acquisition Philosophy:

Busch also emphasized a shift in Siemens’ acquisition philosophy. Traditionally, Siemens often sought out companies with substantial revenue and established market positions. Now, the focus is shifting towards smaller, more agile companies with disruptive technologies and innovative business models. This reflects a recognition that rapid innovation often originates from smaller, specialized firms. Siemens intends to integrate these acquired technologies quickly into its existing portfolio, leveraging its scale and global reach to accelerate their market adoption.

Challenges and Outlook:

While Siemens’ financial position is strong, the M&A landscape is becoming increasingly competitive. Valuations for promising technology companies are high, and larger players like Schneider Electric, ABB, and Honeywell are also actively seeking acquisitions. Successfully integrating acquired companies and retaining key talent will also be crucial challenges.

Despite these challenges, Busch remains optimistic. He believes Siemens is well-positioned to capitalize on the ongoing digital transformation and the growing demand for sustainable technologies. The strategic focus on operations software, AI, and life sciences reflects a clear vision for the future – one where Siemens plays a leading role in shaping the next generation of industrial and healthcare innovation. The coming years will be key to observing how Siemens translates this ambitious acquisition strategy into tangible results and solidifies its position as a technology powerhouse.